Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Authors
Keywords
-
Journal
Scientific Reports
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-06-17
DOI
10.1038/s41598-023-36642-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Functions of IL-33 in Homeostasis and Immunity
- (2022) Gaelen K. Dwyer et al. Annual Review of Immunology
- Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
- (2022) Ahmed J Yousuf et al. Lancet Respiratory Medicine
- Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial
- (2021) Steven G. Kelsen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rapid systemic surge of IL-33 after severe human trauma: a prospective observational study
- (2021) Olav Sundnes et al. MOLECULAR MEDICINE
- Quality control of protein reagents for the improvement of research data reproducibility
- (2021) Ario de Marco et al. Nature Communications
- Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
- (2021) Klaus F Rabe et al. Lancet Respiratory Medicine
- Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33
- (2021) Angela J Okragly et al. Journal of Inflammation Research
- Development of a potent high-affinity human therapeutic antibody via novel application of recombination signal sequence–based affinity maturation
- (2021) Agnieszka Kielczewska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
- (2021) Michael E. Wechsler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages
- (2020) Yuning Lu et al. IMMUNITY
- In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region
- (2020) Kalliopi Skamaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review
- (2019) Alessandro Tonacci et al. Medicina-Lithuania
- IL-33trap is a novel IL-33 neutralizing biologic that inhibits allergic airway inflammation
- (2019) Aurora Holgado et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structural Basis of IL-1 Family Cytokine Signaling
- (2019) James K. Fields et al. Frontiers in Immunology
- Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma
- (2018) Nadia Nicholine Poulsen et al. RESPIRATORY MEDICINE
- A network map of IL-33 signaling pathway
- (2018) Sneha M. Pinto et al. Journal of Cell Communication and Signaling
- Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases
- (2018) Wei-Yu Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage
- (2018) Ian C. Scott et al. Scientific Reports
- IL-33: biological properties, functions, and roles in airway disease
- (2017) Li Yin Drake et al. IMMUNOLOGICAL REVIEWS
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma
- (2017) Dirk Smith et al. PLoS Genetics
- The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
- (2017) Brad Griesenauer et al. Frontiers in Immunology
- IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival
- (2017) Ozkan Gungor et al. PLoS One
- Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics
- (2016) Danlin Yang et al. ANALYTICAL BIOCHEMISTRY
- Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1
- (2016) Seunghyun Jo et al. CYTOKINE
- Alternative splicing of interleukin-33 and type 2 inflammation in asthma
- (2016) Erin D. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble ST2—Analytical Considerations
- (2015) Thomas Mueller et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Biology of ST2: The International ST2 Consensus Panel
- (2015) Domingo A. Pascual-Figal et al. AMERICAN JOURNAL OF CARDIOLOGY
- Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
- (2015) Ari B. Molofsky et al. IMMUNITY
- Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection
- (2015) Jennifer Kearley et al. IMMUNITY
- Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
- (2015) Inna S. Afonina et al. IMMUNITY
- Single-experiment displacement assay for quantifying high-affinity binding by isothermal titration calorimetry
- (2015) Georg Krainer et al. METHODS
- Identification of a large set of rare complete human knockouts
- (2015) Patrick Sulem et al. NATURE GENETICS
- Large-scale whole-genome sequencing of the Icelandic population
- (2015) Daniel F Gudbjartsson et al. NATURE GENETICS
- Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
- (2015) E. Suzanne Cohen et al. Nature Communications
- Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
- (2014) Juliana Bessa et al. JOURNAL OF AUTOIMMUNITY
- Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope “tags”
- (2014) Jennifer L Percival-Alwyn et al. mAbs
- Modeling protein association mechanisms and kinetics
- (2013) Huan-Xiang Zhou et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
- (2013) Derek E. Byers et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity
- (2013) Maria AT Groves et al. mAbs
- Structural insights into the interaction of IL-33 with its receptors
- (2013) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mast Cells Respond to Cell Injury through the Recognition of IL-33
- (2012) Carolina Lunderius-Andersson et al. Frontiers in Immunology
- The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
- (2011) Hideaki Kouzaki et al. JOURNAL OF IMMUNOLOGY
- Whole-Molecule Antibody Engineering: Generation of a High-Affinity Anti-IL-6 Antibody with Extended Pharmacokinetics
- (2011) Donna K. Finch et al. JOURNAL OF MOLECULAR BIOLOGY
- XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases
- (2011) Alexander M. Owyang et al. mAbs
- The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
- (2009) Elvire Bourgeois et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes
- (2009) Andreas Lingel et al. STRUCTURE
- The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33
- (2008) Gaby Palmer et al. CYTOKINE
- IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
- (2008) M. D. Smithgall et al. INTERNATIONAL IMMUNOLOGY
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophils
- (2008) W. Brett Cherry et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens
- (2008) C. Lloyd et al. PROTEIN ENGINEERING DESIGN & SELECTION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started